Bioregenx (BRGX) Total Non-Current Liabilities (2021)
Bioregenx (BRGX) posted quarterly Total Non-Current Liabilities of $151399.0 for Q4 2021.
Bioregenx (BRGX) Total Non-Current Liabilities (2021) Analysis & Trends
Bioregenx's Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $151399.0 for Q4 2021.
- In Q4 2021, Total Non-Current Liabilities changed N/A year-over-year to $151399.0; the TTM figure through Dec 2021 stood at $151399.0 (changed N/A YoY), while the FY2021 annual figure was $151399.0, changed N/A from the prior year.
- Total Non-Current Liabilities for Q4 2021 stood at $151399.0.
- The five-year high for Total Non-Current Liabilities was $151399.0 in Q4 2021, with the low at $151399.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 3.85 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 1.12 Bn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 197.96 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 702.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.88 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 157.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 64.43 Mn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 151,399.00 |